GGrantIndex
← Leaderboards

Neel Rajnikant Gandhi

Columbia University Health Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$17,446,737
Attributed
$21,795,523
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY2010–25
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,698,784 · 11

By mechanism

R01$13,365,306 · 5
P30$5,309,300 · 3
U19$4,803,110 · 1
K24$1,790,880 · 1
R21$430,188 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis”

Research focus

TuberculosisClinical ResearchSouth AfricaResistanceMycobacterium TuberculosisEnrollmentUnited States National Institutes Of HealthCommunicable DiseasesInnovationFundingFutureInfectionIncidenceCohortCountryEpidemicEnsureExposure ToCommunitiesGenomicsPredispositionTransmission ProcessGenotypeSite

Grant awards (45)

Emory/Georgia TB Research Advancement Center (TRAC)$972,283
P30 · FY2025 · AI · contact PI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa$722,084
R01 · FY2025 · AI
Emory/Georgia TB Research Advancement Center (TRAC)$470,441
P30 · FY2025 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$972,283
P30 · FY2024 · AI · contact PI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa$722,947
R01 · FY2024 · AI
Emory/Georgia TB Research Advancement Center (TRAC)$405,779
P30 · FY2024 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$972,285
P30 · FY2023 · AI · contact PI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa$832,182
R01 · FY2023 · AI
Emory/Georgia TB Research Advancement Center (TRAC)$332,536
P30 · FY2023 · AI · contact PI
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health$184,334
K24 · FY2023 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$986,410
P30 · FY2022 · AI · contact PI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection$776,825
R01 · FY2022 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$197,283
P30 · FY2022 · AI · contact PI
Epigenetic Study of Resistance to Infection by Mycobacterium tuberculosis$195,625
R21 · FY2022 · AI
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health$184,334
K24 · FY2022 · AI · contact PI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection$775,211
R01 · FY2021 · AI · contact PI
Epigenetic Study of Resistance to Infection by Mycobacterium tuberculosis$234,563
R21 · FY2021 · AI
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health$184,334
K24 · FY2021 · AI · contact PI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection$738,076
R01 · FY2020 · AI · contact PI
Clinical Core$615,050
U19 · FY2020 · AI · contact PI
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health$184,334
K24 · FY2020 · AI · contact PI
Clinical Core$750,528
U19 · FY2019 · AI · contact PI
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study$720,951
R01 · FY2019 · AI · contact PI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection$713,405
R01 · FY2019 · AI · contact PI
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health$184,334
K24 · FY2019 · AI · contact PI
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study$780,707
R01 · FY2018 · AI · contact PI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection$725,925
R01 · FY2018 · AI · contact PI
Clinical Core$574,879
U19 · FY2018 · AI · contact PI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health$173,842
K24 · FY2018 · AI · contact PI
Clinical Core$1,211,543
U19 · FY2017 · AI · contact PI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health$173,842
K24 · FY2017 · AI · contact PI
Clinical Core$599,707
U19 · FY2016 · AI · contact PI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health$173,842
K24 · FY2016 · AI · contact PI
Clinical Core$550,305
U19 · FY2015 · AI · contact PI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health$173,842
K24 · FY2015 · AI · contact PI
Transmission of HIV-Associated XDR TB in Rural South Africa$711,468
R01 · FY2014 · AI · contact PI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB$641,261
R01 · FY2014 · AI · contact PI
Clinical Core$501,098
U19 · FY2014 · AI · contact PI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health$173,842
K24 · FY2014 · AI · contact PI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB$757,290
R01 · FY2013 · AI · contact PI
Transmission of HIV-Associated XDR TB in Rural South Africa$696,939
R01 · FY2013 · AI · contact PI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB$891,740
R01 · FY2012 · AI · contact PI
Transmission of HIV-Associated XDR TB in Rural South Africa$550,929
R01 · FY2012 · AI · contact PI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB$778,882
R01 · FY2011 · AI · contact PI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB$828,484
R01 · FY2010 · AI · contact PI